Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2025-12-25 @ 12:16 AM
NCT ID:
NCT01003158
Eligibility Criteria:
Inclusion Criteria:
* Cancer that is refractory to standard therapies, or for which no standard therapies exist (monotherapy part)
* Patients suitable for Paclitaxel chemotherapy, who are not candidates for hormonal and anthracycline therapy (combination part)
* Life expectancy more than 12 weeks
Exclusion Criteria:
* Inadequate kidney, liver, heart, gastric, lung or eye function
* Brain metastases
* Hypersensitive to paclitaxel (combination part)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT01003158
Study Brief:
Protocol Section:
NCT01003158